SCHEMBL231287

SCHEMBL231287

CC(C)c1n[nH]c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11010898 0.72 GAA (0.43) —
SCHEMBL10159729 0.72 — —
SCHEMBL11399167 0.70 — —
SCHEMBL19085970 0.67 ALDH1A1 (0.38) —
SCHEMBL21217825 0.67 RAB9A (0.36) —
SCHEMBL8182082 0.66 — —
SCHEMBL11012295 0.65 ALPL (0.48) —
SCHEMBL28142305 0.65 GAA (0.44) —
SCHEMBL19219036 0.65 ALDH1A1 (0.31) —
SCHEMBL251874 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110982330-A Lightfast pink primary pigment red for solvent type ink and preparation method thereof 吴江山湖颜料有限公司 2020-04-10 — — CN claimed
US-20260001886-A1 ENPP1 INHIBITORS I RE VENTURES I LLC (US) 2026-01-01 — — US disclosed
WO-2025233863-A1 ENPP1 INHIBITORS RE VENTURES I, LLC (US) 2025-11-13 — — WO disclosed
WO-2023205173-A1 SUBSTITUTED PIPERIDINES AND SUBSTITUTED TETRAHYDROPYRIDINES AS IMMUNE-MODULATING COMPOUNDS BLACKSMITH MEDICINES, INC. (US) 2023-10-26 — — WO disclosed
CN-114517027-A Preparation method of pigment red 81 杭州红妍颜料化工有限公司 2022-05-20 — — CN disclosed
US-11191765-B2 Heterocyclic compounds for the inhibition of PASK BIOENERGENIX LLC (US) 2021-12-07 — — US disclosed
US-11191765-B2 Heterocyclic compounds for the inhibition of PASK BIOENERGENIX LLC (US) 2021-12-07 — — US disclosed
CN-110982330-A Lightfast pink primary pigment red for solvent type ink and preparation method thereof 吴江山湖颜料有限公司 2020-04-10 — — CN disclosed
CN-110982330-A Lightfast pink primary pigment red for solvent type ink and preparation method thereof 吴江山湖颜料有限公司 2020-04-10 — — CN disclosed
EP-1600442-B1 HETEROARYLCARBAMOYLBENZENE DERIVATIVE MSD KK (JP) 2018-01-17 — — EP disclosed
EP-2385945-A1 TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD Bayer Pharma Aktiengesellschaft (DE) 2011-11-16 — — EP disclosed
US-8041896-B2 Virtualization platform with dedicated cache access HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2011-10-18 — — US disclosed
US-7999107-B2 Psychological disorders; cognition activators; Alzheimer's disease; headaches; nervous system antiinflammatory agents; antiepileptic agents; Parkinson's disease; Huntington's disease; schizophrenia; eating disorders MERCK SHARP & DOHME CORP. (US) 2011-08-16 — — US disclosed
WO-2010078953-A1 TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-07-15 — — WO disclosed
US-7754743-B2 Heteroarylcarbamoylbenzene derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-07-13 — — US disclosed
US-20090018056-A1 Heteroarylcarbamoylbenzene derivatives MSD K.K. (JP) 2009-01-15 — — US disclosed
US-7432287-B2 Heteroarylcarbamoylbenzene derivative BANYU PHARMECEUTICAL CO., LTD. (JP) 2008-10-07 — — US disclosed
US-20080207666-A1 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators MERCK SHARP & DOHME CORP. 2008-08-28 — — US disclosed
US-20060167053-A1 Heteroarylcarbamoylbenzene derivative MSD K.K. (JP) 2006-07-27 — — US disclosed
EP-1600442-A1 HETEROARYLCARBAMOYLBENZENE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-30 — — EP disclosed
Send feedback